Trial Profile
Phase I trial of doxorubin [Doxophos] for the treatment of breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 24 Apr 2015 New trial record